13 results found.

Prostate Cancer, or Prostatic Neoplasms Clinical Trial using Panobinostat; Bicalutamide

New York University School of Medicine - Recruiting 18 years or older.
- Phase I/II Randomized Trial of LBH589 (Panobinostat) at Two Dose Levels Combined With Bicalutamide (Casodex) in Men With Castration-resistant Prostate Cancer.
Panobinostat; Bicalutamide

Adenocarcinoma of the Prostate, Bone Metastases, Hormone-resistan Clinical Trial using sipuleucel-T; external beam radiation therapy; laboratory biomarker analysis

City of Hope Medical Center - Recruiting 18 years or older.
- Randomized Phase II Trial of Sipuleucel T Immunotherapy Preceded by Sensitizing Radiation Therapy and Sipuleucel-T Alone in Patients With Castrate Resistant Metastatic Prostate Cancer.
sipuleucel-T; external beam radiation therapy; laboratory biomarker analysis

Recurrent Prostate Cancer Clinical Trial using High Intensity Focused Ultrasound

USHIFU, LLC - Recruiting 40 years to 85 years.
- A Multicenter Clinical Study of the Sonablater 450 (Sonablate) for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial).
High Intensity Focused Ultrasound

Prostate Cancer, Hormone-resistant Prostate Cancer, Recurrent Pro Clinical Trial using laboratory biomarker analysis; questionnaire administration; doxorubicin-GnRH agonist conjugate AEZS-108

University of Southern California - Recruiting 18 years or older.
- A Phase I/II Trial of AN-152 [AEZS-108) in Castration- and Taxane-Resistant Prostate Cancer.
laboratory biomarker analysis; questionnaire administration; doxorubicin-GnRH agonist conjugate AEZS-108

Diarrhea, Hormone-resistant Prostate Cancer, Recurrent Prostate C Clinical Trial using cabazitaxel; prednisone; octreotide pamoate; questionnaire administration; octreotide acetate

University of Southern California - Recruiting 18 years or older.
- A Phase II Clinical Trial of Cabazitaxel Plus Prednisone With Octreotide in the Treatment of Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel.
cabazitaxel; prednisone; octreotide pamoate; questionnaire administration; octreotide acetate

Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Pro Clinical Trial using stereotactic body radiation therapy; quality-of-life assessment; laboratory biomarker analysis

City of Hope Medical Center - Recruiting 19 years or older.
- Stereotactic Body Radiation Therapy to the Prostate Fossa: Phase I Dose Escalation Study.
stereotactic body radiation therapy; quality-of-life assessment; laboratory biomarker analysis

Progression of Prostate Cancer Clinical Trial using Whole Body MRI; Focal Salvage Therapy; MRI Targeted biopsies

University College London Hospitals - Recruiting 18 years or older.
- An Evaluation of a Novel Imaging Based Complex Diagnostic and Therapeutic Pathway Intervention for Men Who Fail Radiotherapy for Prostate Cancer..
Whole Body MRI; Focal Salvage Therapy; MRI Targeted biopsies

Distal Urethral Cancer, Metastatic Transitional Cell Cancer of th Clinical Trial using gemcitabine hydrochloride; cisplatin; placebo; bevacizumab; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients With Advanced Transitional Cell Carcinoma.
gemcitabine hydrochloride; cisplatin; placebo; bevacizumab; laboratory biomarker analysis

Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Pro Clinical Trial using Akt inhibitor MK2206; bicalutamide; clinical observation

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Androgen Receptor Modulation Phase II, Randomized Study of MK-2206 - Bicalutamide Combination in Patients With Rising PSA at High-Risk of Progression After Primary Therapy.
Akt inhibitor MK2206; bicalutamide; clinical observation

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage Clinical Trial using stereotactic body radiation therapy; quality-of-life assessment; laboratory biomarker analysis

Case Comprehensive Cancer Center - Recruiting 18 years or older.
- High-Dose Stereotactic Body Radiation Therapy in Treating Patients With Low-, Intermediate-, or High-Risk Localized Prostate Cancer.
stereotactic body radiation therapy; quality-of-life assessment; laboratory biomarker analysis

Prostate Cancer Clinical Trial

University of Lausanne Hospitals - Recruiting N/A to 80 years.
- Impact of F-18-Fluorocholine PET/CT and MR Imaging/ Spectroscopy in the Management of Primary and Recurrent Prostate Cancer.

Prostate Cancer Clinical Trial using goserelin acetate; adjuvant therapy; radiation therapy

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Phase III Randomized Study of Adjuvant Radiotherapy With Versus Without Concurrent Goserelin in Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer.
goserelin acetate; adjuvant therapy; radiation therapy

Prostate Cancer Clinical Trial using High Intensity Focused Ultrasound

Lawson Health Research Institute - Recruiting 40 years to 80 years.
- Feasibility Study for Locally Recurrent Prostate Cancer Treatment Following Radiation Failure With High Intensity Focused Ultrasound (HIFU).
High Intensity Focused Ultrasound